BWX Technologies is trading at $159.78 (+4.91%) in pre-market, with no clear company-specific catalyst identified in reliable overnight coverage.

  • BWX Technologies announced an Investor Day for September 29, 2026, without providing new guidance.
  • The previously announced medical-business sale could reach $800 million; it was announced August 3, not September 1.
  • Broader indexes were lower, and confidence in the move’s explanation remains limited.